Gene · 7014
Papers3,508
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,508
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Large-Scale Clustered Transcriptional Silencing Associated With Cellular Senescence. | Aging Cell | 2025 | 39968744 | PubTator, text mining | PubMed |
| Locking the gates of immortality: targeting alternative lengthening of telomeres (ALT) pathways. | Med Oncol | 2025 | 39964637 | PubTator, text mining | PubMed |
| Design, synthesis, and biological evaluation of Flavokavain B derivatives as potent TRF2 inhibitors for the treatment of Osteosarcoma. | Eur J Med Chem | 2025 | 39874631 | PubTator, text mining | PubMed |
| Peptide design to control protein-protein interactions. | Chem Soc Rev | 2025 | 39817557 | PubTator, text mining | PubMed |
| BIBR1532 inhibits proliferation and metastasis of esophageal squamous cancer cells by inducing telomere dysregulation. | World J Gastrointest Oncol | 2025 | 39817136 | PubTator, text mining | PubMed |
| Autoregulation of TRF2 through G-Quadruplex-Specific Interaction between the Gene and N-Terminal Domain of the Protein. | Biochemistry | 2025 | 39705116 | PubTator, text mining | PubMed |
| The Annexin A1 Protein Mimetic Peptide Ac2-26 prevents cellular senescence of CHON-001 chondrocytes against tumor necrosis factor-α via the Nrf2/NF-κB pathway. | Biotechnol Appl Biochem | 2025 | 39574304 | PubTator, text mining | PubMed |
| CSP7 Protects Alveolar Epithelial Cells by Targeting p53-Fibrinolytic Pathways During Lung Injuries. | Am J Respir Cell Mol Biol | 2025 | 39269467 | PubTator, text mining | PubMed |
| Author Correction: Discovery of a selective TRF2 inhibitor FKB04 induced telomere shortening and senescence in liver cancer cells. | Acta Pharmacol Sin | 2025 | 39198664 | PubTator, text mining | PubMed |
| Strong and selective interactions of palmatine with G-rich sequences in TRF2 promoter; experimental and computational studies. | J Biomol Struct Dyn | 2025 | 38100552 | PubTator, text mining | PubMed |
| Alterations of Hepcidin and Iron Markers Associated with Obesity and Obesity-related Diabetes in Gambian Women. | Wellcome Open Res | 2024 | 40895225 | PubTator, text mining | PubMed |
| Telomere length sensitive regulation of interleukin receptor 1 type 1 (IL1R1) by the shelterin protein TRF2 modulates immune signalling in the tumour microenvironment. | Elife | 2024 | 39728924 | PubTator, text mining | PubMed |
| Combatting cellular immortality in cancers by targeting the shelterin protein complex. | Biol Direct | 2024 | 39578854 | PubTator, text mining | PubMed |
| 3D-Q-FISH/Telomere/TRF2 Nanotechnology Identifies a Progressively Disturbed Telomere/Shelterin/Lamin AC Complex as the Common Pathogenic, Molecular/Spatial Denominator of Classical Hodgkin Lymphoma. | Cells | 2024 | 39513855 | PubTator, text mining | PubMed |
| Phase-separated chromatin compartments: Orchestrating gene expression through condensation. | Cell Insight | 2024 | 39512706 | PubTator, text mining | PubMed |
| The expression of shelterin genes and telomere repeat analysis and their effect on Alzheimer's disease. | Mol Biol Rep | 2024 | 39503976 | PubTator, text mining | PubMed |
| Tracing the Chromatin: From 3C to Live-Cell Imaging. | Chem Biomed Imaging | 2024 | 39483638 | PubTator, text mining | PubMed |
| α-Terpineol Induces Shelterin Components TRF1 and TRF2 to Mitigate Senescence and Telomere Integrity Loss via A Telomerase-Independent Pathway. | Antioxidants (Basel) | 2024 | 39456511 | PubTator, text mining | PubMed |
| G-quadruplex DNA and RNA in cellular senescence. | Front Aging | 2024 | 39444378 | PubTator, text mining | PubMed |
| Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression. | Adv Sci (Weinh) | 2024 | 39377984 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7014/papers?page=5